Benchmark indexes Dow Jones, Nasdaq, and the S&P 500 are poised to finish the week on a positive note. We have seen notable performances from four key stocks:
Moderna's Q4 earnings per share of $0.55 and revenue of $2.8 billion exceeded consensus estimates, attributed to reduced expenses and payment delays.
Nvidia reported record revenues of $22.10 billion, up 22% from the third quarter and 265% from a year earlier, beating expectations. Earnings per share were $5.16, up 28% from the previous quarter and 486% from a year earlier, surpassing consensus estimates.
Walmart exceeded analyst estimates with earnings per share of $1.80 and revenue of $173.4 billion for the quarter, along with a quarterly dividend increase of 9.2% to $0.6225 per share.
Tenaris saw 2023 revenues of $14.869 billion, a 26% increase from 2022, and net income rose to $3.958 billion, a 55% improvement over 2022. The board intends to propose a dividend payment of $0.60 per share at the upcoming shareholders' meeting on April 30.
In this piece, we will analyze each stock using InvestingPro's Fair Value. The Fair Value is determined for each stock based on various financial models tailored to the stocks' specific metrics.
For Moderna, InvestingPro's Fair Value, which summarizes 12 investment models, stands at $105.98.
Source: InvestingPro
Analysts are strongly bullish on the stock, with a target price of $134.03 and consequently far from the average Fair Value.
While analysts and Fair Value disagree on the possibility of bullishness and target price, the low-risk profile is positive. It has good financial health, with a score of 3 out of 5.
Delving deeper into the stock with the market and competitors, the stock is currently undervalued.
Source:
Read more on investing.com